0000929638-24-002569.txt : 20240724 0000929638-24-002569.hdr.sgml : 20240724 20240723193046 ACCESSION NUMBER: 0000929638-24-002569 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240724 DATE AS OF CHANGE: 20240723 EFFECTIVENESS DATE: 20240724 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Medcura, Inc. CENTRAL INDEX KEY: 0001672180 ORGANIZATION NAME: IRS NUMBER: 260649449 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-456056 FILM NUMBER: 241135828 BUSINESS ADDRESS: STREET 1: 5650 RIVERTECH COURT, SUITE S CITY: RIVERDALE STATE: MD ZIP: 20737 BUSINESS PHONE: 301-405-3585 MAIL ADDRESS: STREET 1: 5650 RIVERTECH COURT, SUITE S CITY: RIVERDALE STATE: MD ZIP: 20737 FORMER COMPANY: FORMER CONFORMED NAME: gel-e, Inc. DATE OF NAME CHANGE: 20160919 FORMER COMPANY: FORMER CONFORMED NAME: Remedium Technologies, INC. DATE OF NAME CHANGE: 20160413 D/A 1 primary_doc.xml X0708 D/A LIVE 0001672180 Medcura, Inc. 5650 RIVERTECH COURT Suite S RIVERDALE MD MARYLAND 20737 3014053585 DELAWARE None gel-e, Inc. Remedium Technologies, INC. Corporation true Jim Buck c/o Medcura, Inc. 5650 Rivertech Court, Suite S Riverdale MD MARYLAND 20737 Director Executive Officer Mr. Buck is the President and Chief Executive Officer of the Issuer. Larry Tiffany c/o Medcura, Inc. 5650 Rivertech Court, Suite S Riverdale MD MARYLAND 20737 Director Executive Officer Mr. Tiffany is the Executive Chairman of the Issuer. Matthew Dowling, Ph.D c/o Medcura, Inc. 5650 Rivertech Court, Suite S Riverdale MD MARYLAND 20737 Director Executive Officer Dr. Dowling is the Chief Scientic Officer of the Issuer. Rich Vincent c/o Medcura, Inc. 5650 Rivertech Court, Suite S Riverdale MD MARYLAND 20737 Executive Officer Mr. Vincent is the Chief Financial Officer of the Issuer. Abbas Ardehali, M.D. c/o Medcura, Inc. 5650 Rivertech Court, Suite S Riverdale MD MARYLAND 20737 Director Biotechnology Decline to Disclose 06b true 0001567619-22-016358 2022-07-29 false true true true true true Convertible Promissory Notes; Common Stock or Series A-1 Preferred Stock underlying the convertible promissory notes. false 0 None None Donald Capital LLC 297763 420 Lexington Avenue, 14th Floor, Suite New York NY NEW YORK 10170 AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA GA GEORGIA IL ILLINOIS NV NEVADA NJ NEW JERSEY NM NEW MEXICO NY NEW YORK NC NORTH CAROLINA OK OKLAHOMA PA PENNSYLVANIA SC SOUTH CAROLINA TN TENNESSEE TX TEXAS UT UTAH WI WISCONSIN WY WYOMING 22800000 22486953 313047 false 151 118956 0 0 false Medcura, Inc. /s/ Jim Buck Jim Buck President and CEO for the Issuer 2024-07-21